ABVC Biopharma Ties Executive Compensation to $1B Market Cap Milestone
I'm PortAI, I can summarize articles.
ABVC Biopharma Inc. has introduced a performance incentive plan for its directors and officers, contingent on achieving a $1 billion market cap for 30 consecutive trading days by December 31, 2027. Eligible participants will receive shares equal to 1% of the company's outstanding common stock, with a total award cap of $10 million and individual grants capped at $1 million, pending Board approval.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments